U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Tue Apr 01 20:52:50 GMT 2025
Edited
by admin
on Tue Apr 01 20:52:50 GMT 2025
Protein Type BISPECIFIC ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
ZAM5J1ATF2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CIBISATAMAB
INN   USAN  
Official Name English
RG7802
Preferred Name English
ANTI-CEA/CD3 BISPECIFIC ANTIBODY RO6958688
Common Name English
HUMANIZED IMMUNOGLOBULIN G1 (IGG1) T-CELL BISPECIFIC (TCB) ANTIBODY TARGETING CARCINOEMBRYONIC ANTIGEN (CEA) AND CD3 EPSILON CHAIN (CD3E) ON T-CELLS
Common Name English
IMMUNOGLOBULIN G1-KAPPA/LAMBDA WITH DOMAIN CROSSOVER, ANTI-(HOMO SAPIENS CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CD66E ANTIGEN)) AND ANTI-(HOMO SAPIENS T-CELL SURFACE GLYCOPROTEIN CD3 EPSILON CHAIN (CD3E ANTIGEN)) HUMANIZED MONOCLONAL
Systematic Name English
RO6958688
Code English
CEA CD3 TCB
Common Name English
CIBISATAMAB [USAN]
Common Name English
RO-6958688
Code English
cibisatamab [INN]
Common Name English
IMMUNOGLOBULIN G1, HUMANIZED BISPECIFIC TRIVALENT, ANTI-(HUMAN CARCINOEMBRYONIC ANTIGEN/HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) BIVALENT .GAMMA.-CHAIN, DISULFIDE WITH ANTI-(HUMAN CARCINOEMBRYONIC ANTIGEN) .KAPPA.-CHAIN, ANTI-(HUMAN CARCINOEMBRYONIC ANTIGEN) M
Systematic Name English
Cibisatamab [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C129822
Created by admin on Tue Apr 01 20:52:50 GMT 2025 , Edited by admin on Tue Apr 01 20:52:50 GMT 2025
NCI_THESAURUS C28227
Created by admin on Tue Apr 01 20:52:50 GMT 2025 , Edited by admin on Tue Apr 01 20:52:50 GMT 2025
FDA ORPHAN DRUG 618817
Created by admin on Tue Apr 01 20:52:50 GMT 2025 , Edited by admin on Tue Apr 01 20:52:50 GMT 2025
Code System Code Type Description
SMS_ID
100000177955
Created by admin on Tue Apr 01 20:52:50 GMT 2025 , Edited by admin on Tue Apr 01 20:52:50 GMT 2025
PRIMARY
CAS
2101242-53-7
Created by admin on Tue Apr 01 20:52:50 GMT 2025 , Edited by admin on Tue Apr 01 20:52:50 GMT 2025
PRIMARY
USAN
FG-176
Created by admin on Tue Apr 01 20:52:50 GMT 2025 , Edited by admin on Tue Apr 01 20:52:50 GMT 2025
PRIMARY
CAS
1855925-27-7
Created by admin on Tue Apr 01 20:52:50 GMT 2025 , Edited by admin on Tue Apr 01 20:52:50 GMT 2025
ALTERNATIVE
INN
10636
Created by admin on Tue Apr 01 20:52:50 GMT 2025 , Edited by admin on Tue Apr 01 20:52:50 GMT 2025
PRIMARY
FDA UNII
ZAM5J1ATF2
Created by admin on Tue Apr 01 20:52:50 GMT 2025 , Edited by admin on Tue Apr 01 20:52:50 GMT 2025
PRIMARY
NCI_THESAURUS
C120097
Created by admin on Tue Apr 01 20:52:50 GMT 2025 , Edited by admin on Tue Apr 01 20:52:50 GMT 2025
PRIMARY
From To
1_22 1_96
1_148 1_204
1_257 1_333
1_387 1_447
1_508 1_568
1_614 1_672
5_22 5_90
2_22 2_96
3_23 3_88
4_23 4_88
3_135 3_195
4_135 4_195
5_138 5_194
2_148 2_204
1_467 5_214
1_224 3_215
2_224 4_215
1_473 2_230
1_476 2_233
2_265 2_325
1_601 2_353
2_371 2_429
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_544
N 2_301
Related Record Type Details
T-CELL SURFACE GLYCOPROTEIN CD3 EPSILON CHAIN
TARGET -> ACTIVATOR
Related Record Type Details
CIBISATAMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966